Strathdon takes 5% stake in Oxsensis
Strathdon Investments Plc has announcedthat it has made an initial investment of £100,000 for a 5% equity interest in Oxsensis, a spinout from the CCLRC (Council for the Central Laboratory of the ResearchCouncils) Rutherford Appleton Laboratory (RAL). The total funding round raised £890,000 with Strathdon co-investing alongside Seven Spires Investments, RainbowSeed Fund and prominent private investors to accelerate the development of the Company'sextreme environment sensors.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater